ECM
PTLA
Endurant Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-20,803
| Closed | -$786K | – | 91 |
|
|
2018
Q2 | $786K | Sell |
20,803
-50,697
| -71% | -$1.92M | 0.34% | 51 |
|
|
2018
Q1 | $2.34M | Sell |
71,500
-36,100
| -34% | -$1.18M | 0.87% | 30 |
|
|
2017
Q4 | $5.24M | Buy |
107,600
+7,200
| +7% | +$350K | 1.6% | 25 |
|
|
2017
Q3 | $5.43M | Buy |
100,400
+81,200
| +423% | +$4.39M | 1.64% | 22 |
|
|
2017
Q2 | $1.08M | Buy |
+19,200
| New | +$1.08M | 0.3% | 64 |
|
|
2015
Q4 | – | Sell |
-8,700
| Closed | -$371K | – | 86 |
|
|
2015
Q3 | $371K | Buy |
+8,700
| New | +$371K | 0.12% | 71 |
|